期刊文献+

心衰合剂对慢性心力衰竭患者作用的临床观察 被引量:20

Clinical Observation of Xinshuai Mixture in the Treatment of Chronic Heart Failure
下载PDF
导出
摘要 目的观察心衰合剂对慢性心力衰竭(CHF)患者心功能及心肌细胞凋亡相关因子的影响。方法将诊断为CHF的70例患者随机分为两组,各35例。对照组按西医常规进行治疗;治疗组在对照组基础上,根据辨证应用心衰合剂方加减进行治疗。观察治疗前后患者临床症状、脑钠肽水平、左室射血分数及左室舒张末径值、细胞凋亡相关因子sFas/Apo-1、sFasL。结果治疗后治疗组症状、体征积分低于对照组,差异有统计学意义(P<0.05);治疗组与对照组治疗后BNP下降、LVEF上升、LVED下降,治疗组BNP下调与LVEF升高较对照组明显(P<0.05);两组治疗后血清中sFas/Apo-1、sFasL含量较治疗前均显著降低(P<0.01);治疗组sFas/Apo-1及sFasL水平较对照组明显降低(P<0.05)。结论心衰合剂能够有效改善心衰患者的临床症状,降低患者脑钠肽水平,改善患者心功能,抑制心肌细胞的凋亡。 Objective To observe the impacts of xinshuai mixture on heart function and the relevant factors of myocardial apoptosis for the patients with chronic heart failure(CHF). Methods 70 cases with the diagnosis as CHF were randomized into two groups,35 cases in each. In a control group, the conventional western medicine was provided. In a treatment group,on the basis of the conventional western medicine treat- ment, the modified xinshuai mixture was prescribed according to pattern/syndrome differentiation. Before and after treatment,the clinical symptoms,brain natriuretic peptide(BNP) level, the left ventrieular ejection frac- tion(LVEF) ,the left ventrieular end diastolic diameter(LVEDD) , and the relevant factors of apoptosis such as sFas/Apo - 1 and sFasL were observed. Results After the treatment,the scores of symptoms and physical signs in the treatment group were lower than those in the control group, presenting the significant difference in comparison(P 〈 0.05 ). After treatment, in the treatment group and the control group, BNP was reduced, LVEF was increased and LVEDD was decreased. In the treatment group, the down - regulation of BNP and the increasing of LVEF were obvious as compared with the control group ( P 〈 0. 05 ). In both groups, after treatment, the contents of serum sFas/Apo - 1 and sFasL were reduced significantly as compared with those before treatment( P 〈 0. 01 ). The levels of sFas/Apo - 1 and sFasL in the treatment group were lower appar- ently than those in the control group ( P 〈 0.05 ). Conclusion Xinshuai mixture effectively relieves the clini- cal symptoms for the patients with heart failure, reduces BNP level,improves the heart functions of the pa- tients and inhibits myocardial apoptosis.
出处 《世界中西医结合杂志》 2012年第9期768-771,共4页 World Journal of Integrated Traditional and Western Medicine
基金 北京市优秀人才项目(No.2010D003034000024) 北京中医药大学重点实验室对外开放课题(No.2011-SYSKFKT-01-3)
关键词 心衰合剂 慢性心力衰竭 临床观察 Xinshuai Mixture Chronic Heart Failure(CHF) Clinical Observation
  • 相关文献

参考文献9

  • 1朱文锋.中医内科疾病诊疗规范[M].长沙:湖南科学技术出版社.1999:239.
  • 2许心如.心衰合剂治疗充血性心力衰竭30例临床观察[J].中医杂志,1983,(11):25-25.
  • 3韦懿馨,黄丽娟,李祖珍,魏执真,夏军,许心如.益气活血泻肺利水法治疗充血性心力衰竭240例(附基本方初步药理研究)[J].广西中医药,1991,14(6):245-247. 被引量:16
  • 4安海英,黄丽娟,金敬善,金玫,刘红旭.益气温阳和活血利水法对充血性心力衰竭患者神经内分泌系统的影响[J].中国中西医结合杂志,2002,22(5):349-352. 被引量:96
  • 5Kalra PR, Anker SD, Struthers AD,et al. The role of C-type natriuret- ic peptide in cardiovascular medicine [ J ]. Eur Heart J, 2001,22 (12) :997 - 1007.
  • 6Nakagawa O,Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy[J]. J Clin Invest, 1995,96(3) :1280 - 1287.
  • 7Seixas - Cambao M, Leite - Moreira AF. Pathophysiology of chronic heart failure [ J ]. Rev Port Cardio1,2009,28 (4) :439 - 471.
  • 8吕晋琳,杨丽霞.Fas/FasL系统与慢性心力衰竭[J].国际病理科学与临床杂志,2008,28(2):122-125. 被引量:2
  • 9Setsuta K, Seino Y, Ogawa T, et al. Ongoingmyocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system [ J ]. Circ J ,2004,68 (8) :747 -750.

二级参考文献24

  • 1黄立锋,姚咏明.双阴性调节性T细胞在免疫抑制中的作用及其机制[J].国际病理科学与临床杂志,2007,27(2):93-99. 被引量:11
  • 2Jianli N, Asim A, Michael F,et al. Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1 [ J ]. Mol Cell Cardiol,2006, 40(6) :810-820.
  • 3Liao X, Wang X, Gu Y,et al. Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis [ J ] . Life Sci, 2005,77 (2) : 160-174.
  • 4Detlef W, Madhulika C, Khanh N,et al. A mechanistic role for cardiac myocyte apoptosis in heart failure [ J ]. Clin Invest, 2003, 111(10) : 1497-1504.
  • 5Li Y, Takemura G, Kosai K,et al. Critical roles for the Fas/FasL ligand system in postinfarction ventricular remodeling and heart failure [J]. Circ Res,2004,95(6) :627-636.
  • 6Kanamori H, Takemura G, Li Y,et al. Inhibition of Fas-associated apoptosis in granulation tissue cells accompanies attenuation of postinfarction left ventricular remodeling by ohnesartan [J]. Am J Physiol Heart Circ Physiol,2007,292 ( 5 ) : H2184-2194.
  • 7Blanco-Colio LM, Martin-Venture JL, de Teresa E, et al. Increased soluble Fas plasma levels in ,subject at high cardiovascular risk: Atorvastain on inflammatory markers (AIM) study, astbstudy of ACTFAST [ J]. Arterioscler Thromb Vase Biol, 2007,27 ( 1 ) : 168-174.
  • 8Sliwa K, Woodiwiss A, Kone VN,et al. Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: resuits of a randomized study [ J ]. Circulation, 2004,109 (6) :750- 755.
  • 9Bakir HY, Tomiyam-Miyaji C, Watanabe H, et al. Reasons why DBA/2 mice are resistant to malarial infection: expansion of CD3 int B220 ^+ gammadelta T cells with double-negative CD4^ - CD8^ - phenotype in the liver[ J ]. J Immunol, 2006,117 ( 1 ) : 127-135.
  • 10Huber SA, Sartini D, Exley MV. CD4( + ) T cells promote autoimmune CD8 ( + ) cytolytic T-lymphocyte activation in coxcackie virus B3 induced myocarditis in mice :role for CD4( + ) Th1 cells [J]. Virol,2002,76(21) : 10785-10790.

共引文献111

同被引文献167

引证文献20

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部